Catalyst Wire Dossier Catalyst Wire Dossier

DTG dual regimen

dolutegravir-based dual regimen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTG dual regimen, covering 2019-08-13 to 2019-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Inflammatory and Immunological Changes of HIV-positive Patients Switching to DTG Dual Regimen Compared to Those Switching to a Triple Drugs Regimen (B/F/TAF) [Phase 4]

See pricing